How the Non-Alcoholic Steatohepatitis (NASH) Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theNon-Alcoholic Steatohepatitis (NASH) Market?
The increase in obesity rates is a significant factor propelling the non-alcoholic steatohepatitis (NASH) market. Obesity, defined as abnormal or excessive fat accumulation that carries health risks, as well as weight that exceeds the healthy range for a person’s height, is becoming more prevalent. The incidence of non-alcoholic fatty liver disease is escalating in parallel with the obesity crisis, so it is predicted that in the coming years, NASH may emerge as the leading cause of serious liver disease. This is fuelling the demand for NASH treatments and associated medications. For example, the World Health Organization (WHO), a UK-based global health organization, reported in March 2024 that about 2.5 billion adults of 18 years and above were diagnosed as overweight in 2022, with 890 million of them suffering from obesity. Hence, the escalation in obesity rates is set to spur the growth of the non-alcoholic steatohepatitis (NASH) market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8805&type=smp
#What is the Projected CAGR for the Non-Alcoholic Steatohepatitis (NASH) Market Size from 2025 to 2034?
The market size for non-alcoholic steatohepatitis (NASH) has experienced substantial growth in previous years. The market is expected to elevate from $4.5 billion in 2024 to $6.13 billion in 2025, progressing at a compound annual growth rate (CAGR) of 36.1%. Factors contributing to the growth during the historical period include an increased incidence of NASH and obesity, heightened awareness and diagnoses, changes in lifestyle and diets, and advancements in healthcare infrastructure.
The market for non-alcoholic steatohepatitis (NASH) is projected to experience substantial expansion in the coming years. The market is expected to surge up to $19.07 billion by 2029, advancing at a compound annual growth rate (CAGR) of 32.8%. Factors contributing to this growth in the projected period involve progress in the development of NASH medication, enhanced efforts in NASH screening, escalating healthcare costs, cooperative investigations, and government backing and rules. Key developments during the forecasted period encompass emphasis on lifestyle alterations and patient knowledge-expansion, heightened collaboration in clinical studies and examinations, advancements in regulatory frameworks, allocation of medicinal routes, and implementation of artificial intelligence in diagnosis and monitoring processes.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8805
Which Cutting-Edge Market Trends Are Expected to Drive the Non-Alcoholic Steatohepatitis (NASH) Market’s Growth?
Top corporations in the non-alcoholic steatohepatitis (NASH) market are advancing thyroid hormone receptor-beta (THR-beta) agonists to boost liver metabolism, diminish the build-up of liver fat, and improve liver functionality. These are substances that specifically activate the THR-beta receptor subtype, a significant receptor in the control of metabolism, growth, and development. For instance, in March 2024, the USA’s regulatory body, the Food and Drug Administration, gave approval to Rezdiffra (resmetirom), a THR-beta agonist, as the initial treatment for adults suffering from noncirrhotic NASH with moderate to severe liver scarring, also known as fibrosis. Rezdiffra helps regulate lipid metabolism by specifically activating the THR-beta receptor, resulting in a decrease in intrahepatic triglycerides and overall reduction of liver fat accumulation.
What Are the Leading Market Players Impacting theNon-Alcoholic Steatohepatitis (NASH) Market’s Growth Trend?
Major companies operating in the non-alcoholic steatohepatitis (NASH) market include NGM Biopharmaceuticals Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, The Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Genfit SA, Cadila Pharmaceuticals Ltd., Intercept Pharmaceuticals Inc., Enanta Pharmaceuticals Inc., Blade Therapeutics Inc., Galmed Pharmaceuticals Inc., Immuron Limited, Terns Pharmaceuticals Inc., Tobira Therapeutics Inc., Arena Pharmaceuticals Inc., Galectin Therapeutics Inc., Viking Therapeutics, Madrigal Pharmaceuticals Inc., Cirius Therapeutics, Akero Therapeutics Inc., Echosens.
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Non-Alcoholic Steatohepatitis (NASH) Market Driving Opportunities and Innovations?
The non-alcoholic steatohepatitis (NASH) market covered in this report is segmented –
1) By Type: Solid, Liquid
2) By Product: Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Other Products
3) By Disease Cause: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity
4) By Sales Channel: Hospital Pharmacy, Retail Pharmacy, Online Provider
5) By Application: Oral, Parenteral
Subsegments:
1) By Solid: Tablets, Capsules, Other Solid Dosage Forms
2) By Liquid: Oral Solutions, Syrups, Injectable Solutions, Other Liquid Dosage Forms
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8805&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theNon-Alcoholic Steatohepatitis (NASH) Market?# Market Expansion?
North America was the largest region in the non alcoholic steatohepatitis (NASH) market share in 2024. The regions covered in the non-alcoholic steatohepatitis (nash) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Non-Alcoholic Steatohepatitis (NASH) Market 2025, By The Business Research Company:
Propylene-Petrochemicals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/propylene-petrochemicals-global-market-report
Petrochemicals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/petrochemicals-global-market-report
Water-Based Adhesives Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/waterbased-adhesives-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
